Deborah Grayson, who is also a nutritional therapist, says weight-loss injection companies will have to update their ...

SOLANA BEACH, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical ...

Q: How do you think the FDA's compassionate use withdrawal will impact the competitive landscape for gastroparesis treatments ...

Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...

Investment analysts at StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research note issued on Wednesday. The firm set a “sell” rating on the specialty ...

Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

It’s “time to get rid of this age-old practice,” said Sripal Bangalore, who noted that patients are happier when not fasting.

Gastroparesis is a chronic disorder that affects a significant subset of the population. Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the ...

A teenager from Thalassery, Kerala, recently died due to anorexia. Prolonged absence of proper nutrition and extreme methods ...

J Gastroenterol Hepatol. 2007;22(9):1423-1428. The diagnosis of gastroparesis was not made in any of our patients, despite severe symptoms, until they were referred to adult or pediatric ...